Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

10 treatments under study, led by Rege Pro Dressing

Research Leaders

6 sponsors active, led by Egyptian Atomic Energy Authority

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (5)

Trial Status

Completed4
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (5)

Research Network

Common Treatments

  • Rege Pro Dressing1
  • Prf Mixed With Phmb Plus Macrogolol1
  • Conventional Ordinary Dressing1
  • Normal Saline Dressing1
  • Prf Mixed With Amikacin And Teicoplanin1

Active Sponsors

  • Egyptian Atomic Energy Authority1
  • Waleed Nemr,Egyptian Atomic Energy Authority1
  • Zagazig University1
  • Medical University of Vienna1
  • Multan Medical And Dental College1

Top Investigators

Related Conditions

  • Diabetic Foot Ulcer1
  • Plasma Protein Transport Protein1
  • Diabetic Foot1
  • Ulcer Foot1
  • Epidermolysis Bullosa1

Activity Timeline